These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20519658)

  • 1. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study.
    Klingensmith GJ; Pyle L; Arslanian S; Copeland KC; Cuttler L; Kaufman F; Laffel L; Marcovina S; Tollefsen SE; Weinstock RS; Linder B;
    Diabetes Care; 2010 Sep; 33(9):1970-5. PubMed ID: 20519658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes.
    Buzzetti R; Spoletini M; Zampetti S; Campagna G; Marandola L; Panimolle F; Dotta F; Tiberti C;
    Diabetes Care; 2015 Mar; 38(3):513-20. PubMed ID: 25567348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
    Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
    Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet cell autoimmunity in youth onset diabetes mellitus in Northern India.
    Goswami R; Kochupillai N; Gupta N; Kukreja A; Lan M; Maclaren NK
    Diabetes Res Clin Pract; 2001 Jul; 53(1):47-54. PubMed ID: 11378213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.
    Pilla SJ; Balasubramanyam A; Knowler WC; Lazo M; Nathan DM; Pi-Sunyer X; Clark JM; Maruthur NM;
    Autoimmunity; 2018 Dec; 51(8):408-416. PubMed ID: 30661481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
    Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
    Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in children with type 2 diabetes mellitus.
    Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():525-30. PubMed ID: 12017227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
    Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
    J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients.
    Pardini VC; Mourao DM; Nascimento PD; Vívolo MA; Ferreira SR; Pardini H
    Braz J Med Biol Res; 1999 Oct; 32(10):1195-8. PubMed ID: 10510254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet autoantibody status in a multi-ethnic UK clinic cohort of children presenting with diabetes.
    Perchard R; MacDonald D; Say J; Pitts J; Pye S; Allgrove J; Banerjee K; Amin R
    Arch Dis Child; 2015 Apr; 100(4):348-52. PubMed ID: 25409982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
    Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
    Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
    Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
    Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
    Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
    Gambelunghe G; Forini F; Laureti S; Murdolo G; Toraldo G; Santeusanio F; Brunetti P; Sanjeevi CB; Falorni A
    Clin Endocrinol (Oxf); 2000 May; 52(5):565-73. PubMed ID: 10792335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic autoimmune markers in children and adolescents with type 2 diabetes.
    Hathout EH; Thomas W; El-Shahawy M; Nahab F; Mace JW
    Pediatrics; 2001 Jun; 107(6):E102. PubMed ID: 11389300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
    Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
    Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus.
    Willis JA; Scott RS; Brown LJ; Forbes LV; Schmidli RS; Zimmet PZ; MacKay IR; Rowley MJ
    Diabetes Res Clin Pract; 1996 Jul; 33(2):89-97. PubMed ID: 8879963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.